Page 328 - ESHRE2019

P-767 Risk of morbidity in pregnancies and deliveries after In Vitro Fertilization: a French comparative observational cohort of 43,084 IVF versus non-IVF deliveries 2013-2016
M. Valentin1, S. Epelboin2, R. Levy3, F. Merlet4, M. Bergère4, F. Pessione5
1Hôpital Bichat-Claude Bernard- Assistance Publique-Hôpitaux de Paris- Université Paris 7 Diderot, Gynecology Obstetrics, Paris, France
2Hôpital Bichat-Claude Bernard- Assistance Publique-Hôpitaux de Paris- Université Paris 7 Diderot, Gynecology Obstetrics and Reproductive Medecine, Paris, France
3Hôpital Tenon- Assistance Publique Hôpitaux de Paris- Université Paris 6 Pierre et Marie Curie, Embryology Reproductive Biology, Paris, France
4Agence de la Biomédecine, Procreation Embryology Genetics, Paris, France
5Agence de la Biomédecine, Procreation Embryology Genetics Biostatistics, Paris, France
P-768 Birth size in children born after cryopreservation of embryo in assisted reproduction compared to fresh embryo transfer and spontaneous conception
E. Landsverk1, K. Westvik-Johari2, L.B. Romundstad3, S. Opdahl4
1Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, Trondheim, Norway
2Trondheim University Hospital, Department of Fertility- St Olavs Hospital, Trondheim, Norway 3Norwegian Institute of Public Health, Centre for Fertility and Health, Oslo, Norway
4Faculty of Medicine and Health Sciences- Norwegian University of Science and Technology, Department of Public Health and Nursing, Trondheim, Norway
P-769 Assisted reproductive technology (ART) and neurodevelopmental outcome at 4 years of preterm infants
T. Freour1, P.E. Bouet2, P. Barriere1, G. Gascoin3, V. Rouger4, M. Olivier4, J.C. Roze5, C. Flamant5, J.B. Muller5
1CHU Nantes, reproductive medicine, Nantes, France 2CHU Angers, reproductive medicine, Angers, France 3CHU Angers, neonatology, Angers, France
4CHU Nantes, Loire Infant Follow-up Team, nantes, France 5CHU Nantes, neonatology, nantes, France
P-770 The role of Cabergoline and post-collection Gonadotropin Releasing Hormone – antagonist administration for Ovarian Hyperstimulation Syndrome prevention after agonist trigger
M. Dahan1, G. Shrem2, N. Steiner3, J. Balayla4, A. Volodarsky-Perel3, S. Tannus3, W. Son3 1McGill University, McGill University Health Center Reproductive Center, Montreal- QC, Canada 2McGill University, Reproductive Medicine, Montreal, Canada
3McGill University, Reproductive MEdecine, Montreal, Canada
4McGill University, Ob Gyn, Montreal, Canada
328